Skip to main content
. 2015 Mar 5;3(1):130–145. doi: 10.3390/healthcare3010130

Table 4.

Overuse of OAC (Number of patients discordant with the non-OAC treatment recommendation by decision aids).

Stroke Risk Bleeding Risk AHA Aggressive AHA Conservative Casciano CHEST ESC LaHaye
Low (CHA2DS2-VASc score = 0) Low (HAS-BLED score = 0) 627 (38.51%) 627 (38.51%) 627 (38.51%) 627 (38.51%) 627 (38.51%) 627 (38.51%)
Medium (HAS-BLED score = 1 or 2) 176 (40.09%) 176 (40.09%) 176 (40.09%) 176 (40.09%) 176 (40.09%) 176 (40.09%)
High (HAS-BLED score ≥ 3) 1 (16.67%) 1 (16.67%) 1 (16.67%) 1 (16.67%) 1 (16.67%) 1 (16.67%)
Sub-total 804 (38.78%) 804 (38.78%) 804 (38.78%) 804 (38.78%) 804 (38.78%) 804 (38.78%)
Medium (CHA2DS2-VASc score = 1 Low (HAS-BLED score = 0) ARO 403 (38.64%) 262 (30.82%) 261 (30.81%) ARO 403 (38.64%)
Medium (HAS-BLED score = 1 or 2) ARO 1041 (49.74%) 331 (45.84%) 264 (44.90%) ARO 1041 (49.74%)
High (HAS-BLED score ≥ 3) ARO 34 (55.74%) 23 (54.76%) 4 (100.00%) 34 (55.74%) 34 (55.74%)
Sub-total ARO 1478 (46.23%) 616 (38.17%) 529 (36.76%) 34 (55.73%) 1478 (46.23%)
High (CHA2DS2-VASc score ≥ 2) Low (HAS-BLED score = 0) ARO ARO 25 (36.76%) 19 (31.15%) ARO ARO
Medium (HAS-BLED score = 1 or 2) ARO ARO 486 (48.07%) 163 (45.03%) ARO 3167 (55.29%)
High (HAS-BLED score ≥ 3) ARO ARO 293 (48.83%) 9 (60.00%) ARO 1044 (55.68%)
Sub-total ARO ARO 804 (47.88%) 191 (43.61%) ARO 4211 (55.38%)
Overall Total 804 (38.78%) 2282 (43.30%) 2224 (41.45%) 1564 (39.59%) 838 (39.27%) 6493 (50.43%)

Data is presented as n (%) of patients who are not consistent with the non- OAC treatment recommendation by each decision aid. ARO: Always recommends OAC. AHA Aggressive: AHA guidelines (assuming that guideline recommends OAC at CHA2DS2-VASc = 1), AHA Conservative: AHA guidelines (assuming that guideline recommends non-OAC at CHA2DS2-VASc = 1), Casciano: Casciano tool, CHEST: CHEST guidelines, ESC: ESC guidelines, LaHaye: LaHaye tool.